1E Therapeutics is a drug-development company creating RNA-targeting therapeutics based on a proprietary drug-design platform.
1E's process has proven able to develop drugs that address chronic life-threatening indications as well as emerging and evolving pathogens. 1E already has lead compounds that address a wide array of indications in oncology, age-related diseases, immunology, anti-microbial resistance, viral infections, and orphan neurological disorders.
Cumulative Funding Raised Over Time ($)
Employees Over Time
1E Therapeutics Climate Tech relevance
null
Latest News
No Data, yet.
Sorry, no content found under this section.
Dec 8, 2021
www.calcalistech.com
Mysterious Israeli biotech company raises $120 million Seed round five months after founding